AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...

Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...

Celltrion’s senior executives attended the conference to present the company’s latest progress in new drug development and long-term growth strategy. The presentation took place on Tuesday, January 13 ...

In this GEN webinar, experts from Perceptive Imaging and Flywheel explore how imaging data access issues slow decision-making and increase risks for both biopharma and CROs.

"With Ensemble, sponsors can finally consume AI as amanaged capability that blends technology with deep functional expertise," said Jian Chen, Chief Executive Officer of EDETEK. "It is a practical ...

Title: Gemini restores normal innate immune response in CKD patients Presenter: Robin Marsden, Senior Vice President of Biology, Revelation Biosciences Date/Time: Sunday, March 29, 2026 5:30 p.m.

Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 ...

As part of conversations between AI healthcare leaders on the podcast AI Amplified this year, a clear picture emerged of where artificial intelligence is genuinely transforming healthcare — and where ...

For years, one of the biggest barriers to effectively implementing artificial intelligence (AI) into clinical trial data management has been a lack of trust in its capabilities. Although this concern ...

The highly fragmented nature of the healthcare industry is a key driver behind private equity’s pursuit of clinical data exchange assets. Hospitals and healthcare practices are still highly siloed, ...